FDA Investigator Sarah M Meng

Sarah M Meng has conducted inspections on 32 sites in 7 countries as of 21 Jan 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
21 Jan 2016
Investigator Role:
FDA Investigator
Redica ID:
100000572
Countries of Inspections:
United States of America, Denmark, Switzerland, Germany, Japan, France, Spain
FDA Investigators that have inspected at least one site in common with Sarah M Meng:
Alanna L Mussawwir Bias, Alexandra A Carrico, Alice S Tsao, Amy S Graf, Andrea F White, Anita Narula, PhD, Ann Raju Daniel, Anna Lazar, Anthony F Lorenzo, Anthony R Petriella, Art O Czabaniuk, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Barbara J Rincon, Bei Y He, Benjamin J Smith, Bernice F Hirsch, Brentley S Collins, Brian M Campbell, Brian P Putz, Burnell M Henry, Carmen M Faraianu, Caroline H Le, Charisse K Green, Charles L Zhou, Charles M Edwards, Charles M Spyr, Cheng H Yen, Cheryl A Fuhs, Cheryl M Monroe, Christian D Lynch (CDL), Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Cynthia A Palmer, Daniel J Brown, Daniel L Obrzut, Darren S Morgan, David A Paterson, David J Gasparovich, David Perkins, Deborah M Trout, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Eric S Pittman, Franklin D Heisler, Gary C Pecic, Jr, Geneve M Maxwell, Geneve M Parks, Ginger M Sykes, Hans T Meyers, Helen B Ricalde, Ifueko Osemwota, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James R Evans, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Schmidt, Joanne E King, Jogy George, Joohi Castelvetere, Joseph A Piechocki, Joseph T Madak, Karen K Moksnes, Karen Takahashi, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Kejun Cheng, Kenneth H Williams, Kham Phommachanh, Khoa Nathanv Tran, Kristina Nastovski, Kristy A Zielny, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Lata C Mathew, PhD, Laureen F Kononen, Lauren E Sexton, Lauren M Lilly, PhD, Laurimer Kuilan Torres, LCDR Chad N Thompson, Leslie A Paul, Lindsey Brown, PhD, Lisa J Joseph, Lisa M Bellows, Lisa M Feola, Lisa T Michel, Logan T Williams, Luis Mburgos Medero, Mark R Mcclain, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Meisha R Sampson, Meisha Waters, Miah I Schneider, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Mihaly S Ligmond, Natalie A Mickelsen, DVM, Nicholas A Violand, Omotunde O Osunsanmi, Paraluman S Leonin, Paranthaman Senthamaraikannan, Parul M Patel, Patsy J Domingo, Paula A Trost, Peng Zhou, Prabhu P Raju, Rabin N Ghoshal, Ralph A Erickson, Raymond R Roy, PhD, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Renee L Rice, PhD, Robert M Barbosa, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Rose Ashley, Rose Xu, Ryan J Benedict, Saied A Asbagh, Salwa K Poole, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Napier, Scott T Ballard, Sharon K Thoma, PharmD, Sheryl A Duquet, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Steven D Kehoe, Susan M Jackson, Taichun Qin, PhD, Thomas E Friel, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Veronica Fuentes, MS, Victoria A Murray, Vilmary Negron Rodriguez, Wendy M Stark, William A Warnick, William D Tingley, Yiwei Li, Yumi J Hiramine

Sarah M Meng's Documents

Publish Date Document Type Title
May, 2013 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2013-05-30
November, 2014 FDA 483 Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483, 2014-11-13
April, 2014 FDA 483 Zoetis LLC - Form 483, 2014-04-17
March, 2014 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2014-03-13
December, 2015 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2015-12-04
December, 2014 FDA 483 Coram Healthcare Corp. of Indiana - Form 483, 2014-12-16
March, 2013 FDA 483 Xela Pack, Inc. - Form 483, 2013-03-01
August, 2013 FDA 483 Lannett Company, Inc. - Form 483, 2013-08-27
November, 2014 FDA 483 Response Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483R, 2014-11-13
February, 2015 FDA 483 Response AMERICAN PHARMACEUTICAL INGREDIENTS LLC d.b.a American Pharmaceutical Distributors - Form 483R, 2015-02-10
September, 2015 FDA 483 ENDO USA, Inc. - Form 483, 2015-09-10
March, 2013 FDA 483 Corteva Agriscience LLC - Form 483, 2013-03-21
September, 2015 EIR ENDO USA, Inc. - EIR, 2015-09-10
February, 2015 FDA 483 AMERICAN PHARMACEUTICAL INGREDIENTS LLC d.b.a American Pharmaceutical Distributors - Form 483, 2015-02-10
September, 2014 FDA 483 L. Perrigo Company - Form 483, 2014-09-04
April, 2015 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2015-04-24
July, 2013 FDA 483 Beacon Hill Medical Pharmacy, P.C. - Form 483, 2013-07-19
January, 2016 FDA 483 KEYBIO - Form 483, 2016-01-13
May, 2013 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2013-05-10
May, 2013 EIR Baxter Pharmaceutical Solutions LLC - EIR, 2013-05-10
January, 2016 FDA 483 Berlimed SA - Form 483, 2016-01-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more